[1] Catnach S M, Fairclough P D.Erythromycin and the gut [J] .Fairclough Gut ,1992, 33(3): 397-401. [2] Itoh Z, Nakaya M,Suzuki T, et al.Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog[J] .Am J Physiol ,1984 ,247(6): G688-694. [3] Tomomasa T,Kuroume T,Arai H,et al.Erythromycin induces migrating motor complex in human gastrointestinal tract[J]. Dig Dis Sci ,1986,31(2): 157-161. [4] Peeters T,Matthijs G,Depoortere I,et al.Erythromycin is a motilin receptor agonist[J].Am J Physiol ,1989,257(3) :G470-474. [5] Parkman H P, Pagano A P,Vozzelli M A, et al.Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach[J].Am J Physiol, 1995,269(3): G418-426. [6] Ung D,Parkman H P,Nagar S.Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis[J]. Xenobiotica,2009,39(10): 749-756. [7] Inatomi N,Satoh H,Maki Y,et al. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs[J]. Pharmacol Exp Ther, 1989 ,251(2): 707-712. [8] Shiba Y,Mizumoto A,Satoh M, et al. Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in consciousdogs[J].Gastroenterology, 1996 ,110(1): 241-250. [9] Depoortere I,Peeters T L.Domonstration and characterization of motilion-binding sites in the rabbits cerebellum[J]. Am J Physiol,1997, 272: G994-999. [10] Liu H,Qiu D,Zhou X, et al.Erythromycin inhibited glycinergic inputs to gastric vagal motoneurons in brainstem slices of newborn rats[J]. Neurogastroenterol Motil,2010,22(11): 1232-9. [11] Lim C H, Choi M G, Park H, et al.Effect of DA-9701 on gastric emptying in a mouse model: Assessment by C-13-octanoic acid breath test[J].World Journal of Gastroenterology,2013,19: 4380-4385. [12] Otterson, M. F. and S. K. Sarna Gastrointestinal motor effects of erythromycin[J].Am J Physiol,1990,259(3): G355-363. [13] Oei J,Lui K. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants[J].Acta Paediatr,2001,90(8): 904-8. [14] 张志群,李慧萍,朱建幸. 静脉应用小剂量红霉素防止早产儿喂养不耐受的META分析[J]. 中国询证儿科杂志,2009,4(3):281-288. [15] Saliakellis E , Fotoulaki M.Gastroparesis in children[J].Ann Gastronenterol 2013 ,26(3):204-211. [16] Camilleri M,Parkman H P,Shafi M A,et al.Clinical guideline: mana gement of gastroparesis. [J].Am J Gastroenterol, 2013, Jan,108(1): 18-37. [17] Richards R D, Davenport K, McCallum R W.The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin[J].Am J Gastroenterol,1993, 88(2): 203-207. [18] 陈建群,丁银云,张萍. 红霉素、西沙必利治疗新生儿胃轻瘫48例效果比较[J].南通大学学报(医学版) , 2005, 25(4): 292-293. [19] Mozwecz H,Pavel D,Pitrak D.Erythromycin sterate as prokinetic agent in pastragotomy gastroparesis[J]. Dig Dis Sci,1990,35 :902-905 [20] Liu J F, Liu C J, Shi Z H,et al.Effect of erythromycin on electrical activity and gastric emptying of the intrathoracic stomach after esophagectomy for esophageal cancer[J],Zhonghua Wei Chang Wai Ke Za Zhi,2013,16(9): 878-880. [21] Urbain J L, Vantrappen G, Janssens J,et al. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids [J]. J Nucl Med,1990,31(9): 1490-1493. [22] Larson J M, Tavakkoli A, Drane W E.Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adultpatients with gastroparesis[J].J Neurogastroenterol Motil,2010,Oct;16:407-13. [23] Wang,Y.Clinical effects of erythromycin combined with cisapride or domperidone in treatment of type 2 diabetic gastroparesis[J].World Chinese Journal of Digestology,2014, 22(30): 4709-4713. [24] 范丽.红霉素与莫沙必利联合治疗糖尿病胃轻瘫的疗效分析[J].医学理论与实践, 2015, 28(9): 1193-1194. [25] Landry C. Vidon N, Sogni P, et al.Could oral erythromycin optimize high energy continuous enteral nutrition? [J].Aliment Pharmacol Ther,1996, 10(6): 967-973. [26] 卢年芳.红霉素联合甲氧氯普胺治疗重症监护病房机械通气患者胃排空障碍[J].中国新药与临床杂,2010,29(5): 336-340. [27] Nguyen N Q., Chapman M J, Fraser R J, et al.Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness[J].Crit Care Med, 2007,35(2): 483-489. [28] Deane A M, Fraser R J, Chapman M J.Prokinetic drugs for feed intolerance in critical illness: current and potential therapies[J].Crit Care Resusc,2009, 11: 132-143. [29] Onoma M, Ozaki K, Yogo K, et al.Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.Clin Exp Pharmacol Physiol,2008,35(7):788-96. [30] 董梅,王丹华,丁国芳,等.极低出生体重儿胃肠喂养的临床观察[J].中国儿科杂志,2003, 41(2):87-90. [31] Boivin MA, Carey M C ,Howard L.Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects[J]. Pharmacotherapy,2003,23(1): 5-8. [32] 胡宝春,李伟.糖尿病性胃轻瘫的药物治疗研究进展[J].武警后勤学院学报,2015.24(2):162-165. [33] Sato F, Marui S, Inatomi N, et al. EM574, an erythromycin derivative,improves delayed gastric emptying of semi-solid meals in conscious dogs[J]. Eur J Pharmacol, 2000, 395(2):165-172. |